Bruderman Asset Management LLC Decreases Holdings in GlaxoSmithKline plc


Bruderman Asset Management LLC trimmed its position in shares of GlaxoSmithKline plc by 34.6% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 170,097 shares of the pharmaceutical company's stock after selling 89,896 shares during the period.



from Biotech News